Similar Papers

Paper Title
Journal
Date
Author
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
Caroline Sindet-Pedersen ... Gunnar H Gislason
Thrombosis Research | VOL. 199
Caroline Sindet-Pedersen, et. al.Caroline Sindet-Pedersen ... Gunnar H Gislason
07 Jan 2021
Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study
Suleman Aktaa ... Chris P Gale
Thrombosis Research | VOL. 202
Suleman Aktaa, et. al.Suleman Aktaa ... Chris P Gale
08 Mar 2021
Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+B-cell repopulation
Nitin Kumar Sahi ... Adnan Al-Araji
Multiple Sclerosis and Related Disorders | VOL. 56
Nitin Kumar Sahi, et. al.Nitin Kumar Sahi ... Adnan Al-Araji
27 Sep 2021
COVID-19 and prostate cancer: a complex scenario with multiple facets.
Felice Crocetto ... Armando Calogero
Future Science OA | VOL. 8
Felice Crocetto, et. al.Felice Crocetto ... Armando Calogero
23 Nov 2021
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Introducing the Breakthrough Beyond the Journal series.
Vlad Ratziu
Journal of hepatology | VOL. 82
Vlad RatziuVlad Ratziu
01 Feb 2025
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie A Razavi ... Eli Zuckerman
Journal of Hepatology | VOL. -
Homie A Razavi, et. al.Homie A Razavi ... Eli Zuckerman
01 Feb 2025
MICROB-PREDICT works on identifying microbiome-based predictors and mechanisms of decompensated liver cirrhosis & ACLF, and develop personalised treatment strategies. Discover the project!
-
Journal of Hepatology | VOL. 82
--
01 Feb 2025
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue ... Xiaojiaoyang Li
Journal of Hepatology | VOL. -
Xiaoyong Xue, et. al.Xiaoyong Xue ... Xiaojiaoyang Li
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.